Literature DB >> 16409550

Lrrk2 R1441 substitution and progressive supranuclear palsy.

O A Ross1, A J Whittle, S A Cobb, M M Hulihan, S J Lincoln, M Toft, M J Farrer, D W Dickson.   

Abstract

Mutation of the LRRK2 gene has been associated with autosomal dominant parkinsonism. An R1441C pathogenic substitution was identified in Family D, a large Western Nebraskan kindred, with four members demonstrating pleomorphic pathology at autopsy. One member of this family displayed tau pathology suggestive of progressive supranuclear palsy (PSP). To evaluate the influence of mutation at the R1441 residue in this disorder we screened a series of 242 pathologically confirmed PSP cases. No evidence was found for the presence of a mutation at this codon in our series. These data would suggest that this Lrrk2 variant does not contribute in susceptibility to PSP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16409550     DOI: 10.1111/j.1365-2990.2006.00693.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  12 in total

1.  LRP10 variants in progressive supranuclear palsy.

Authors:  Leonie J M Vergouw; Shamiram Melhem; Laura Donker Kaat; Wang Z Chiu; Demy J S Kuipers; Guido Breedveld; Agnita J W Boon; Li-San Wang; Adam C Naj; Elizabeth Mlynarksi; Laura Cantwell; Marialuisa Quadri; Owen A Ross; Dennis W Dickson; Gerard D Schellenberg; John C van Swieten; Vincenzo Bonifati; Frank Jan de Jong
Journal:  Neurobiol Aging       Date:  2020-04-30       Impact factor: 4.673

Review 2.  Extrapyramidal syndromes in frontotemporal degeneration.

Authors:  Andrew Kertesz; Paul McMonagle; Sarah Jesso
Journal:  J Mol Neurosci       Date:  2011-09-02       Impact factor: 3.444

3.  Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.

Authors:  Monica Sanchez-Contreras; Michael G Heckman; Pawel Tacik; Nancy Diehl; Patricia H Brown; Alexandra I Soto-Ortolaza; Elizabeth A Christopher; Ronald L Walton; Owen A Ross; Lawrence I Golbe; Neill Graff-Radford; Zbigniew K Wszolek; Dennis W Dickson; Rosa Rademakers
Journal:  Mov Disord       Date:  2016-10-06       Impact factor: 10.338

Review 4.  PARK8 LRRK2 parkinsonism.

Authors:  Kristoffer Haugarvoll; Zbigniew K Wszolek
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

Review 5.  The neuropathology of genetic Parkinson's disease.

Authors:  Markos Poulopoulos; Oren A Levy; Roy N Alcalay
Journal:  Mov Disord       Date:  2012-03-26       Impact factor: 10.338

6.  Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations.

Authors:  A S Chen-Plotkin; W Yuan; C Anderson; E McCarty Wood; H I Hurtig; C M Clark; B L Miller; V M-Y Lee; J Q Trojanowski; M Grossman; V M Van Deerlin
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

7.  Progressive supranuclear palsy in a family with TDP-43 pathology.

Authors:  A Kertesz; E Finger; J Murrell; H Chertkow; L C Ang; M Baker; T Ravenscroft; R Rademakers; D G Munoz
Journal:  Neurocase       Date:  2014-01-30       Impact factor: 0.881

8.  CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity.

Authors:  Han Seok Ko; Rachel Bailey; Wanli W Smith; Zhaohui Liu; Joo-Ho Shin; Yun-Il Lee; Yong-Jie Zhang; Haibing Jiang; Christopher A Ross; Darren J Moore; Cam Patterson; Leonard Petrucelli; Ted M Dawson; Valina L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

Review 9.  Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders.

Authors:  Sonja W Scholz; Jose Bras
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

Review 10.  Genetics of Progressive Supranuclear Palsy.

Authors:  Sun Young Im; Young Eun Kim; Yun Joong Kim
Journal:  J Mov Disord       Date:  2015-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.